ReadiGraft® Demineralized Chips and Particulate

Download the files in the language of your choice
Instructions for Use
Product Specifications

ReadiGRAFT®

ReadiGraft® Demineralized Chips and Particulate

Demineralized bone chips and particulate designed to promote bone healing in patients with a high risk of non-union.

  • Osteoinductive Potential: Demineralized using proprietary PAD® technology that targets optimal residual calcium levels of 1-4% without compromising the grafts inherent osteoconductive properties or osteoinductive potential.1, 2
  •  Osteoconductive: Natural bone matrix facilitates cell attachment, cell proliferation, and vascular in‐growth.
  •  Sterile: Sterilized using proprietary and patented Allowash XG® technology which provides a sterility assurance level of 10-6 , without compromising the graft’s inherent osteoconductive properties.3
  •  Versatile: Available in multiple sizes and volumes to meet surgical needs.
  • Absorbent: Absorbs and retains bioactive fluids like blood, platelet rich plasma (PRP), and bone marrow aspirate (BMA).
Clinical Application

Any surgical application that requires bone void filler

Description Sizing
DCAN40 ReadiGraft Demineralized Cancellous Chips, 1 - 8 mm 40 cc
DCC1/4 ReadiGraft Demineralized Cortical/Cancellous Chips, 1 - 8 mm 20 cc
DGC20 ReadiGraft Demineralized Cortical Particulate, 125-1000 microns 20 cc
DGC40 ReadiGraft Demineralized Cortical Particulate, 125-1000 microns 30 cc
References
  1.  Zhang M, Powers R, Wolfinbarger L. (1997). Effect(s) of demineralization process on the osteoinductivity of demineralized bone matrix. J Periodontol, 68:1085-1092.
  2.  Turonis JW, McPherson JC 3rd, Cuening MF. (2006). The affects of residual calcium in decalcified freeze-dried bone allograft in a critical-sized defect in the Rattus norvegicus calvarium. J Oral Implantol. 32(2), 55-62.
  3.  Balsly CR, Cotter AT, Williams LA, Gaskins BD, Moore MA, Wolfinbarger L Jr. Effect of low dose and moderate dose gamma irradiation on the mechanical properties of bone and soft tissue allografts. Cell Tissue Bank. 2008;9(4):289-298. doi:10.1007/s10561-008-9069-0.